TITLE

IS PROPHYLACTIC BANDING ALWAYS SAFE? RANDOMISED CONTROLLED TRIAL FOR THE PREVENTION OF FIRST VARICEAL BLEEDING IN CIRRHOTIC PATIENTS WITH CONTRAINDICATIONS OR INTOLERANCE TO B BLOCKERS

AUTHOR(S)
Triantos, C.; Vlachogiannakos, J.; Armonis, A.; Saveriadis, A.; Kougioumtzian, A.; Leondro, G.; Manolakopoulos, S.; Raptis, S. A.; Burroughs, A. K.; Avgerinos, A.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA37
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article focuses on a study that explores whether prophylactic banding is always safe, with randomized controlled trial for the prevention of first variceal bleeding in cirrhotic patients with contraindications or intolerance to B blockers. Endoscopic banding ligation (EBL) versus no therapy reduces the risk of First portal hypertensive bleeding, no significant complications being reported. 60% of the bleeding in the banding group was probably iatrogenic, requiring stoppage of the study. EBL was no better than no treatment.
ACCESSION #
13218956

 

Related Articles

  • Strattera: increased risk of suicidal ideation in children and adolescents.  // Reactions Weekly;10/8/2005, Issue 1072, p2 

    Reports on the announcement by Eli Lilly and Co. that the Strattera label for atomoxetine will be updated globally to warn of a possible association between the drug and suicidal ideation in children and adolescents in the U.S. Analysis of adverse events from Strattera clinical trials; Safety...

  • The Medical Dictionary for Regulatory Activities (MedDRA). Brown, E.G.; Wood, L.; Wood, S. // Drug Safety;Feb1999, Vol. 20 Issue 2, p109 

    The International Conference on Harmonisation has agreed upon the structure and content of the Medical Dictionary for Regulatory Activities (MedDRA) version 2.0 which should become available in the early part of 1999. This medical terminology is intended for use in the pre- and postmarketing...

  • The Effect of Forewarning on the Occurrence of Side- effects and Discontinuance of Medication in Patients on Amitriptyline. Myers, E. D.; Calvert, E. J. // British Journal of Psychiatry;Apr73, Vol. 122 Issue 569, p461 

    The article discusses the study on the impact of prevising patients taking amitriptyline on its side-effects. It is believed that psychological factors are significant in identifying the harmful or good effects of drugs. In an amitriptyline trial, patients were asked to note down their...

  • Deferoxamine.  // Reactions Weekly;1/6/2007, Issue 1133, p9 

    The article discusses research being done on a 51-year-old who developed fatal zygomycosis following treatment with deferoxamine. It references a study by V.-C. Wu and colleagues, published in the December 2006 issue of "Kidney International." Information on the medical history of the patient is...

  • Serious Drug Reactions Are On The Rise. Bauer, Jeff; Roman, Linda // RN;Nov2005, Vol. 68 Issue 11, p79 

    Reports on a survey by the U.S. Agency for Healthcare Research and Quality and the National Healthcare for Health Statistics on the increase in the incidence of adverse reactions to medications in the U.S. in 2001. Classes of drugs that were most frequently implicated; Most frequent complaints;...

  • Methadone.  // Reactions Weekly;4/21/2007, Issue 1148, p26 

    The article presents a case study of a 52-year-old woman who developed QTc prolongation and torsade de pointes during treatment with methadone. After she was diagnosed with QTc prolongation and torsade de pointes, the woman received magnesium and lidocaine, as well as ceftriaxone. On day 19 of...

  • Propofol.  // Reactions Weekly;4/21/2007, Issue 1148, p29 

    The article presents a case study of a 36-year-old woman who developed fatal propofol infusion syndrome during treatment with propofol. The woman started receiving an infusion of propofol for sedation after she was hospitalised and diagnosed with non-convulsive status epilepticus. She was...

  • Does this work for you? Christakis, Nicholas A. // BMJ: British Medical Journal (International Edition);11/1/2008, Vol. 337 Issue 7677, p1025 

    The author discusses the rationale in determining whether a drug works or not. He examines the perspective which relies on the results of clinical trials, noting that researchers often pick outcomes which are not patient centred. Critics argue that side effects may make patients think that a...

  • Anecdotes that provide definitive evidence. Aronson, Jeffrey K.; Hauben, Manfred // BMJ: British Medical Journal (International Edition);12/16/2006, Vol. 333 Issue 7581, p1267 

    The article addresses whether some reportings of drug reactions need to be proved by further testing. The authors argue that some adverse drug reactions are so convincing that they do not require clinical trials. They identify four types of adverse events for which further testing is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics